Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer's disease

Neurobiology of Disease

Volumn 37, Issue 2, 2010, Pages 339-348

  Poulopoulou, Cornelia ^a   Markakis, Ioannis ^a   Davaki, Panagiota ^a   Tsaltas, Eleftheria ^a   Rombos, Antonis ^a   Hatzimanolis, Alexandros ^a   Vassilopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alzheimer's disease; Metabotropic glutamate receptors; Potassium channels; T lymphocytes

Indexed keywords

CHOLINESTERASE INHIBITOR; DELAYED RECTIFIER POTASSIUM CHANNEL; DONEPEZIL; GALANTAMINE; GLUTAMIC ACID; METABOTROPIC RECEPTOR 2; POTASSIUM CHANNEL KV1.3; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; MALE; NERVOUS TISSUE; PATCH CLAMP; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; STEADY STATE; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN INFARCTION; CELL MEMBRANE; CELL PROLIFERATION; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HUMANS; ION CHANNEL GATING; KV1.3 POTASSIUM CHANNEL; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE POTENTIALS; MITOGENS; NEUROIMMUNOMODULATION; PATCH-CLAMP TECHNIQUES; PHYTOHEMAGGLUTININS; RECEPTORS, METABOTROPIC GLUTAMATE; T-LYMPHOCYTES;

EID: 73049105334     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.10.012     Document Type: Article

References (42)

1. Albasanz J.L., Dalfó E., Ferrer I., and Martín M. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol. Dis. 20 3 (2005) 685-693
2. Alkon DL. Ionic conductance determinants of synaptic memory nets and their implications for Alzheimer's disease. J. Neurosci. Res. 58 1 (1999) 24-32
3. v1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 103 46 (2006) 17414-17419
4. Boldyrev A.A., Carpenter D.O., and Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem. 95 4 (2005) 913-918
5. Britschgi M., and Wyss-Coray T. Systemic and acquired immune responses in Alzheimer's disease. Int. Rev. Neurobiol. 82 (2007) 205-233
6. Butterfield D.A., and Pocernich C.B. The glutamatergic system and Alzheimer's disease: therapeutic implications. CNS Drugs 17 9 (2003) 641-652
7. Cahalan M.D., Wulff H., and Chandy G. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21 4 (2001) 235-252
8. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 25 5 (2004) 280-289
9. + channels in human T-lymphocytes: a role in mitogenesis?. Nature 307 5950 (1984) 465-468
10. De Silva H.A., Aronson J.K., Grahame-Smith D.G., Jobst K.A., and Smith A.D. Abnormal function of potassium channels in platelets of patients with Alzheimer's disease. Lancet 352 9140 (1998) 1590-1593
11. Disterhoft J.F., and Oh M.M. Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease. J. Physiol. Paris 99 2-3 (2006) 180-192
12. Etcheberrigaray R., Ito E., Oka K., Tofel-Grehl B., Gibson G.E., and Alkon D.L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 17 (1993) 8209-8213
13. Fadool D.A., and Levitan I.B. Modulation of olfactory bulb neuron potassium current by tyrosine phosphorylation. J. Neurosci. 18 16 (1998) 6126-6137
14. v1.3 channel gene-targeted deletion produces "super-smeller mice" with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron 41 3 (2004) 389-404
15. v1.3 channels contribute to their ability to kill neurons. J. Neurosci. 25 31 (2005) 7139-7149
16. Francis P.T. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease. Neurodegener. Dis. 5 3-4 (2008) 241-243
17. Garcia-Calvo M., Leonard R.J., Novick J., Stevens S.P., Schmalhofer W., Kaczorowski G.J., and Garcia M.L. Purification, characterization and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J. Biol. Chem. 268 25 (1993) 18866-18874
18. Ghelardini C., Galeotti N., and Bartolini A. Influence of potassium channel modulators on cognitive processes in mice. Br. J. Pharmacol. 123 6 (1998) 1079-1084
19. Giese K.P., Peters M., and Vernon J. Modulation of excitability as a learning and memory mechanism: a molecular genetic perspective. Physiol. Behav. 73 5 (2001) 803-810
20. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391 2 (1981) 85-100
21. 125I]apamin binding sites in Alzheimer hippocampus: a quantitative autoradiographic study. Brain Res. 567 1 (1991) 51-56
22. V1.3 channel blocker, improves associative learning in rats. Behav. Brain Res. 120 1 (2001) 35-46
23. Kues W.A., and Wunder F. Heterogeneous expression patterns of mammalian potassium channel genes in developing and adult rat brain. Eur. J. Neurosci. 4 12 (1992) 1296-1308
24. Lombardi G., Dianzani C., Miglio G., Canonico P.L., and Fantozzi R. Characterization of ionotropic glutamate receptors in human lymphocytes. Br. J. Pharmacol. 133 6 (2001) 936-944
25. V1.3 potassium channel. Biophys. J. 67 2 (1994) 579-589
26. Mattson M.P. Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J. Neurovirol. 8 6 (2002) 539-550
27. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 7 (1984) 939-944
28. Pacheco R., Gallart T., Lluis C., and Franco R. Role of glutamate on T-cell mediated immunity. J. Neuroimmunol. 185 1-2 (2007) 9-19
29. + channel activity in aged humans. Biochem. Biophys. Res. Commun. 199 2 (1994) 519-524
30. Parameshwaran K., Dhanasekaran M., and Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp. Neurol. 210 1 (2008) 7-13
31. + current. Neurobiol. Aging 27 11 (2005) 1673-1683
32. Poulopoulou C., Davaki P., Koliaraki V., Kolovou D., Markakis I., and Vassilopoulos D. Reduced expression of metabotropic glutamate receptor 2 mRNA in T-cells of ALS patients. Ann. Neurol. 58 6 (2005) 946-949
33. Poulopoulou C., Markakis I., Davaki P., Nikolaou C., Poulopoulos A., Raptis E., and Vassilopoulos D. Modulation of voltage-gated potassium channels in human T-lymphocytes by extracellular glutamate. Mol. Pharmacol. 67 3 (2005) 856-867
34. + memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy. Neuromol. Med. 9 4 (2007) 340-354
35. Schrader L.A., and Tasker J.G. Modulation of multiple potassium currents by metabotropic glutamate receptors in neurons of the hypothalamic supraoptic nucleus. J. Neurophysiol. 78 6 (1997) 3428-3437
36. Shalit F., Sredni B., Brodie C., and Kott E. T-lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immunopathol. 75 3 (1995) 246-250
37. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., and Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med 14 8 (2008) 837-842
38. Solerte S.B., Ceresini G., Ferrari E., and Fioravantini M. Hemorheological changes and overproduction of cytokines in mild to moderate dementia of the Alzheimer's type. Neurobiol. Aging 21 2 (2000) 271-281
39. Sommer M.H., Xavier M.H., Fialho M.B., Wannmacher C.M., and Wajner M. The influence of amino acids on mitogen-activated proliferation of human lymphocytes in vitro. Int. J. Immunopharmacol. 16 10 (1994) 865-872
40. Tyszkiewicz J.P., and Yan Z. beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J. Neurophysiol. 93 6 (2005) 3102-3111
41. + channels. J. Phys. 503 Pt. 2 (1997) 317-331
42. Zhang W., and Linden D.J. The other side of the engram: experience-driven changes in neuronal intrinsic excitability. Nat. Rev., Neurosci. 4 11 (2003) 885-900